Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Cerivastatin sodium

Known as: 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, monosodium salt, (S-(R*,S*-(E)))-, 7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyrid-3-yl)-3,5-dihydroxy-6-heptenoate sodium salt, rivastatin 
The sodium salt of cerivastatin, a synthetic lipid-lowering agent.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
  • T. A. Jacobson
  • The American journal of cardiology
  • 2006
  • Corpus ID: 21409056
Safety has become a central issue in the management of dyslipidemia with statins. A review of New Drug Applications (NDAs) and… 
Highly Cited
2006
Highly Cited
2006
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
Review
2004
Review
2004
ContextIn recent years, US patients have increasingly been the first to receive new medications, some of which are subsequently… 
Review
2004
Review
2004
CONTEXT In recent years, US patients have increasingly been the first to receive new medications, some of which are subsequently… 
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2003
Highly Cited
2003
Background—Despite the development of effective immunosuppressive therapy, transplant graft arterial disease (GAD) remains the… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2000
Review
2000
  • W. Mück
  • Clinical pharmacokinetics
  • 2000
  • Corpus ID: 37073920
Cerivastatin sodium, a novel statin, is a synthetic, enantiomerically pure, pyridine derivative that effectively reduces serum… 
Highly Cited
1999
Highly Cited
1999
A woman with severe coronary disease, diabetes mellitus, and hyperlipidemia presented with recent onset of back pain, profound… 
Highly Cited
1999
Highly Cited
1999
The aim of this study was to examine whether cerivastatin sodium, a new inhibitor of 3‐hydroxy‐3‐methylglutaryl coenzyme A (HMG… 
Highly Cited
1996
Highly Cited
1996
Inhibitors of cholesterol biosynthesis are believed to lower serum cholesterol levels by enhancing the removal of serum low… 
1993
1993
An LC procedure suitable for quantitative analysis of pg ml-1 concentrations of the HMG-CoA reductase inhibitor rivastatin in…